KAREN TEVES-FRAZIER: Open Payments
NPI 1528255247 · TROY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,554 in 213 payments from 19 companies in 2025. Trend: 2023 $5,343 · 2024 $5,492 · 2025 $4,554
Food & beverage: $4,554
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 22 | $680 |
| ABBVIE INC. | 20 | $560 |
| Axsome Therapeutics, Inc. | 16 | $494 |
| Lundbeck LLC | 21 | $390 |
| Collegium Pharmaceutical, Inc. | 19 | $361 |
| Otsuka America Pharmaceutical, Inc. | 14 | $358 |
| Vanda Pharmaceuticals Inc. | 12 | $356 |
| Corium, LLC | 25 | $324 |
| Noven Therapeutics, LLC | 20 | $320 |
| Supernus Pharmaceuticals, Inc. | 17 | $182 |
Products named: REXULTI, CAPLYTA, VRAYLAR, Auvelity, Jornay PM, FANAPT, Azstarys, Xelstrym.
Industry payments across MI — which companies pay providers there.
